[Remote] Project Manager II, eCOA at Clairo

United Kingdom

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalIndustries

Requirements

Bachelor’s degree or equivalent experience in project management
3–5 years of experience in pharmaceutical or related industry
Proven expertise in clinical trial operations and eCOA solutions
Strong proficiency in Microsoft Office and project tracking tools
Demonstrated ability to manage budgets, timelines, and cross-functional teams
Excellent communication and interpersonal skills
Fluency in English

Responsibilities

Lead all phases of study management: planning, setup, monitoring, and closeout
Translate customer requirements into actionable plans for internal teams
Develop and maintain study documentation and reports
Oversee equipment distribution and data archiving
Monitor timelines and manage study budgets, including forecasting and invoice reconciliation
Identify and escalate risks with mitigation strategies
Foster collaboration across internal and external stakeholders
Resolve customer issues using structured problem-solving approaches
Represent Project Management in operational readiness for new product initiatives
Support client meetings and sales efforts as needed
Train and mentor new Project Management team members

Skills

eCOA

Project Management

Clinical Trials

Microsoft Office

Project Tracking Tools

Budget Management

Risk Mitigation

Stakeholder Management

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free